山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (6): 42-48.doi: 10.6040/j.issn.1673-3770.0.2020.094

• • 上一篇    下一篇

内镜经翼突入路切除中颅底恶性肿瘤30例临床分析

郑朝攀1,曾小燕1,张博1,韩灵1,罗曼2,马玲国1   

  1. 1. 深圳市人民医院 耳鼻咽喉科, 广东 深圳 518020;
    2. 深圳市保健委员会办公室, 广东 深圳 518000
  • 发布日期:2021-01-11
  • 通讯作者: 马玲国. E-mail: ljymax@163.com
  • 基金资助:
    深圳市科技创新委员会基础研究项目(JCYJ20190907150811212)

Clinical analysis of the endonasal transpterygoid approach to the resection of malignant tumors involving the middle skull base of 30 cases

ZHENG Chaopan1, ZENG Xiaoyan1, ZHANG Bo1, HAN Lin1, LUO Man2, MA Lingguo1   

  1. 1. Department of Otolaryngology, Shenzhen People Hospital, Shenzhen 518020, Guangdong, China;
    2. Shenzhen Healthcare Committee Office, Shenzhen 518000, Guangdong, China
  • Published:2021-01-11

摘要: 目的 探讨内镜经翼突入路切除中颅底恶性肿瘤的疗效。 方法 回顾分析30例经鼻内镜翼突入路切除累及中颅底恶性肿瘤患者相关资料,总结该手术相关技巧和经验,用Kaplan-Meier法进行生存分析,探讨肿瘤累及颈内动脉对预后影响。 结果 手术均为全身麻醉下进行。平均手术时间145 min,平均术中出血470 mL,术中脑脊液漏6例;术后颅内感染2例、脑脊液漏1例,均痊愈。病理分别为复发性鼻咽癌21例、腺样囊性癌3例、黏液表皮样癌2例、脊索瘤1例、癌肉瘤1例、鼻咽滤泡树突状细胞肉瘤1例和颅底淋巴上皮瘤样癌1例。30例颅底恶性肿瘤患者术后1年、2年、3年、5年生存率分别为92.9%、79.6%、48.6%和36.5%;复发性鼻咽癌中位生存期为29.00[35.00,23.00]个月,其他恶性肿瘤38.00[38.00,38.00]个月,生存曲线之间差异有统计学意义(χ2=4.248; P=0.039);颈内动脉累及和未累及患者中位数分别为16.00[23.00,14.00]个月和36.00[80.00,31.00] 个月,生存曲线差异有统计学意义(χ2=9.421; P=0.002);而且颈内动脉受累是影响患者预后的危险因素,颈内动脉受累及患者的死亡风险是未受累患者的9.678倍(HR=9.678,P=0.011)结论 内镜翼突入路是部分中颅底恶性肿瘤外科治疗的合理方案,颈内动脉累及侵犯是影响疾病预后的危险因素。

关键词: 中颅底, 恶性肿瘤, 内镜, 翼突入路, 颈内动脉

Abstract: Objective To explore the endonasal transpterygoid approach to the resection of malignant tumors involving the middle skull base and its outcomes. Methods The surgery-related data of 30 cases of malignant tumors involving the middle skull base attended to at the Department of Otorhinolaryngology of the Shenzhen People's Hospital between October 2012 and June 2019 were retrospectively analyzed. The skills and experience of the surgeons and the techniques employed during the surgery were summarized. The Kaplan-Meier method was used for survival analysis. The prognoses of the tumor-involved internal carotid arteries were also explored. Results The surgeries, using the endonasal transpterygoid approach, were performed under general anesthesia; the average duration of surgery was 145 minutes, the average intraoperative blood loss was 470 mL, and intraoperative cerebrospinal fluid leakage occurred in 6 cases. The postoperative intracranial infection in 2 cases and the cerebrospinal fluid leakage in 1 case were cured. Pathologically, there were 21 cases of recurrent nasopharyngeal carcinoma, 3 cases of adenoid cystic carcinoma, 2 cases of mucoepidermoid carcinoma, 1 case of chordoma, 1 case of carcinosarcoma, 1 case of nasopharyngeal follicular dendritic cell sarcoma, and 1 case of skull base lymphocytic epithelioma-like carcinoma. The 1-year, 2-year, 3-year, and 5-year survival rates of the 30 patients with malignant tumors were 92.9%, 79.6%, 48.6%, and 36.5%, respectively. The median survival duration was 29.00(35.00, 23.00)months for recurrent nasopharyngeal carcinoma and 38.00(38.00, 38.00)months for other malignant tumors. The survival curves of recurrent nasopharyngeal carcinomas and other malignant tumors showed statistical significance(χ2=4.248; P=0.039). The median durations of survival of patients with and without internal carotid artery invasion were 16.00(23.00, 14.00)and 36.00(80.00, 31.00)months, respectively, and their survival curves were significantly different(χ2=9.421; P=0.002). Internal carotid artery involvement is a risk factor for poor prognosis, and the risk of death of patients with internal carotid artery involvement was 9.678 times that of those without involvement(HR=9.678, P=0.011). Conclusion The endoscopic transpterygoid approach is a reasonable option for the surgical treatment of tumors involving the middle skull base; however, the involvement of the internal carotid artery is an important prognostic factor that should always be considered.

Key words: Middle skull base, Malignant tumor, Endoscope, Transpterygoid approach, Internal carotid artery

中图分类号: 

  • R765.9
[1] Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients[J]. J Neurosurg, 1997, 87(1): 44-51. doi:10.3171/jns.1997.87.1.0044.
[2] Cappabianca P, Alfieri A, de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery(FEPS)[J]. Minim Invasive Neurosurg, 1998, 41(2): 66-73. doi:10.1055/s-2008-1052019.
[3] Kassam AB, Gardner P, Snyderman C, et al. Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal Fossa[J]. Neurosurg Focus, 2005, 19(1): E6.
[4] Kassam AB, Prevedello DM, Carrau RL, et al. The front door to meckel's cave: an anteromedial corridor via expanded endoscopic endonasal approach-technical considerations and clinical series[J].Neurosurgery,2009,64(3):71-82. doi:10.1227/01.neu.0000335162.36862.54.
[5] Belykh E, Yagmurlu K, Lei T, et al. Quantitative anatomical comparison of the ipsilateral and contralateral interhemispheric transcallosal approaches to the lateral ventricle[J]. J Neurosurg, 2018, 128(5): 1492-1502. doi:10.3171/2017.1.JNS161338.
[6] 刘剑锋, 韩军, 杨大章, 等. 内镜经翼突入路的解剖及其在处理颅底病变中的应用[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(11): 909-914. doi:10.3760/cma.j.issn.1673-0860.2015.11.006. LIU Jianfeng, HAN Jun, YANG Dazhang, et al. Surgical anatomy, technique and application of endoscopic endonasal transpterygoid approach in skull base surgery[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2015, 50(11): 909-914. doi:10.3760/cma.j.issn.1673-0860.2015.11.006.
[7] 郑朝攀, 周敬淳, 韩灵, 等. 内镜翼突入路治疗中颅底良性占位性病变[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 51-54. ZHENG Chaopan, ZHOU Jingchun, HAN Ling, et al. The management of benign space-occupying lesion of the middle skull base via the endoscopic pterygopalatine space approaches[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2015, 29(4): 51-54.
[8] Doescher J, Veit JA, Hoffmann TK. The 8th edition of the AJCC Cancer Staging Manual: Updates in otorhinolaryngology, head and neck surgery[J]. HNO, 2017, 65(12): 956-961. doi:10.1007/s00106-017-0391-3.
[9] Truong HQ, Sun XC, Celtikci E, et al. Endoscopic anterior transmaxillary “transalisphenoid” approach to Meckel's cave and the middle cranial fossa: an anatomical study and clinical application[J]. J Neurosurg, 2018, 130(1): 227-237. doi:10.3171/2017.8.JNS171308.
[10] Mehta GU, Raza SM. Endoscopic endonasal transpterygoid approach to petrous pathologies: technique, limitations and alternative approaches[J]. J Neurosurg Sci, 2018, 62(3): 339-346. doi:10.23736/S0390-5616.18.04302-3.
[11] Amit M, Abergel A, Fliss DM, et al. The clinical importance of quality-of-life scores in patients with skull base tumors: a meta-analysis and review of the literature[J]. Curr Oncol Rep, 2012, 14(2): 175-181. doi:10.1007/s11912-012-0222-3.
[12] Vlantis AC, Chan HS, Tong MC, et al. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors[J]. Head Neck, 2011, 33(8): 1126-1131. doi:10.1002/hed.21585.
[13] Na'ara S, Amit M, Billan S, et al. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis[J]. Ann Surg Oncol, 2014, 21(9): 3056-3062. doi:10.1245/s10434-014-3683-9.
[14] Chen MY, Wen WP, Guo X, et al. Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2009, 119(3): 516-522. doi:10.1002/lary.20133.
[15] Chan JYW, Wong STS, Wei WI. Surgical salvage of recurrent T3 nasopharyngeal carcinoma: Prognostic significance of clivus, maxillary, temporal and sphenoid bone invasion[J]. Oral Oncol, 2019, 91: 85-91. doi:10.1016/j.oraloncology.2019.02.023.
[16] Chen MM, Roman SA, Sosa JA, et al. Predictors of survival in sinonasal adenocarcinoma[J]. J Neurol Surg Part B Skull Base, 2015, 76(3): 208-213. doi:10.1055/s-0034-1543995.
[17] Cipriani NA, Lusardi JJ, McElherne J, et al. Mucoepidermoid carcinoma: a comparison of histologic grading systems and relationship to MAML2 rearrangement and prognosis[J]. Am J Surg Pathol, 2019, 43(7): 885-897. doi:10.1097/PAS.0000000000001252.
[18] Bakker SH, Jacobs WCH, Pondaag W, et al. Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival[J]. Eur Spine J, 2018, 27(12): 3043-3058. doi:10.1007/s00586-018-5764-0.
[19] Misra P, Husain Q, Svider PF, et al. Management of sinonasal teratocarcinosarcoma: a systematic review[J]. Am J Otolaryngol, 2014, 35(1): 5-11. doi:10.1016/j.amjoto.2013.04.010.
[20] Pang J, Mydlarz WK, Gooi Z, et al. Follicular dendritic cell sarcoma of the head and neck: Case report, literature review, and pooled analysis of 97 cases[J]. Head Neck, 2016, 38(Suppl 1): E2241-E2249. doi:10.1002/hed.24115.
[21] 刘全, 孙希才, 于华鹏, 等. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45. doi:10.6040/j.issn.1673-3770.1.2019.016. LIU Quan, SUN Xicai, YU Huapeng, et al. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 39-45. doi:10.6040/j.issn.1673-3770.1.2019.016.
[1] 张国民,王茂华,高松,吴文斌,虞幼军. 持续灌流模式耳内镜下粘连性中耳炎手术疗效分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 16-19.
[2] 卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94.
[3] 程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119.
[4] 李帅,黄春燕,常明章. 鼻内镜下鼻中隔软骨尾端偏曲矫正术的临床效果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 65-70.
[5] 刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96.
[6] 王再兴,唐志元,李定波,石照辉,曾宪海,张秋航. 鼻咽癌放疗后肿瘤复发及颅底骨坏死引起颈内动脉破裂的治疗方案[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 49-58.
[7] 孙芳,谢楚波,邱前辉. 营养指标对鼻咽癌放射性颅底坏死患者创面修复影响的回顾性分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 59-68.
[8] 姜知临,朱瑞楷,邱前辉. 基于影像学对咽旁颈内动脉走行的观察与分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 69-76.
[9] 朱瑞楷,吴家荣,孙芳,谢楚波,邱前辉. 基于计算机断层扫描血管造影术评估鼻咽癌放疗后引起颈内动脉狭窄状况及其影响因素的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 77-84.
[10] 覃德波,薛建成,杨文月,胡兵,陈涛,俞艳萍,孟庆国,孙焕吉,苗北平,卢永田. 鼻咽癌诊疗变革:生物标志物与鼻内镜手术协同推进早期治疗发展[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 85-92.
[11] 吴家荣,邱前辉. 颅底筋膜组织在早期复发性鼻咽癌内镜手术中的临床意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 108-113.
[12] 郭荣昌,刘晴航,王洪增,孙树军. 巨大鼻眼贯通、颅底嵌顿异物损伤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 135-141.
[13] 顾月龙,唐如,茆松,张维天. 术后GH与IGF-1水平对非侵袭性垂体生长激素腺瘤远期缓解的预测价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 45-50.
[14] 李晓宇,王彬晨,徐大朋,王艳华,杜平功,张庆泉. 三维建模配准分析经口与经鼻开窗治疗上颌骨囊肿三维形态变化[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 72-78.
[15] 孙乐,张云云,刘浩,叶京英,吴彦桥. 鼻内镜辅助下经口鼻联合入路腭部巨大多形性腺瘤切除术1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 117-122.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!